• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Neurocrine Biosciences Inc

+ Add to Watchlist


13.4500 USD 0.3900 2.82%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Neurocrine Biosciences Inc (NBIX)

Open: 13.7500 Day's Range: 13.3500 - 13.9600 Volume: 485,552
Previous Close: 13.8400 52wk Range: 8.5700 - 20.2900 1-Yr Rtn: +14.66%

Stock Chart for NBIX

No chart data available.
  • NBIX:US 13.4500
  • 1D
  • 1M
  • 1Y
Interactive NBIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBIX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7353
Est. EPS (USD) (12/2014) -0.8420
Est. PEG Ratio -
Market Cap (M USD) 1,020.19
Shares Outstanding (M) 75.85
30 Day Average Volume 999,979
Price/Book (mrq) 7.5232
Price/Sale (ttm) 308.6477
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBIX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBIX

Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.

Kevin C GormanPresident/CEOTimothy P CoughlinChief Financial Officer
Christopher F O'BrienChief Medical OfficerHaig P BozigianChief Development Officer
More Company Profile & Key Executives for NBIX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil